Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.

Hunjan, M K; Roberts, C; Karim, S; Hague, J

Hunjan, M K; Roberts, C; Karim, S; Hague, J.

Hunjan MK; Department of Dermatology, Solihull Hospital, University Hospitals Birmingham Foundation NHS Trust, Birmingham, UK.
Roberts C; Department of Histopathology, Solihull Hospital, University Hospitals Birmingham Foundation NHS Trust, Birmingham, UK.
Karim S; Department of Histopathology, Solihull Hospital, University Hospitals Birmingham Foundation NHS Trust, Birmingham, UK.
Hague J; Department of Dermatology, Solihull Hospital, University Hospitals Birmingham Foundation NHS Trust, Birmingham, UK.

Clin Exp Dermatol ; 47(1): 188-190, 2022 Jan.

Article in English | MEDLINE | ID: covidwho-1352459

ABSTRACT

ABSTRACT

We describe a case of a pityriasis rubra pilaris (PRP)-like eruption occurring following administration of the Pfizer-Biontech mRNA COVID-19 vaccine, with worsening of the condition following the second dose. To our knowledge, this is the first reported case of a PRP-like eruption as a cutaneous adverse event of the Pfizer-Biontech mRNA COVID-19 vaccine.

Subject(s)

BNT162 Vaccine/adverse effects; COVID-19/prevention & control; Drug Eruptions/etiology; Pityriasis Rubra Pilaris/chemically induced; Drug Eruptions/pathology; Humans; Male; Middle Aged; Pityriasis Rubra Pilaris/pathology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pityriasis Rubra Pilaris / Drug Eruptions / COVID-19 / BNT162 Vaccine Type of study: Case report / Observational study Topics: Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Clin Exp Dermatol Year: 2022 Document Type: Article Affiliation country: Ced.14878

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google